E-mail：BD@ebraincase.com

Tel：+8618971215294

[Research Tool Highlight] Featured in Cell! Brain Case launches new product — Enhancer AAV Vectors, a breakthrough for research Tool !

Time：2025-11-12 10:01:01

The mammalian brain, as a highly complex organ, contains a cortex composed of hundreds of distinct cell types. These cells can be classified in multiple dimensions based on shared morphological features, functional properties, and molecular expression profiles. Defining the contribution of each cell type to cortical physiological processes is critical for understanding their roles in both health and disease.

On May 29, 2025, a major milestone of the U.S. NIH BRAIN Initiative was published in Cell. The paper, titled “A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types”, reports that researchers utilized transcriptomic and epigenomic classifications of mouse and human cortical cell types to define marker genes and putative enhancers. They created a large toolkit comprising 15 transgenic driver mouse lines, 2 reporter lines, and over 1,000 enhancer AAV vectors designed for specific targeting of cortical subpopulations, with some tools achieving over 90% specificity.

https://www.cell.com/cell/fulltext/S0092-8674(25)00513-6

All tools have been made available through Addgene and Jackson Labs. Experimental data related to SYFP2 expression vectors in this study can be accessed via the Genetic Tools Atlas network portal — a new public resource developed by the Allen Institute (RRID:SCR_025643; https://portal.brain-map.org/genetic-tools/genetic-tools-atlas) and BioFileFinder (BFF) (RRID:SCR_026930; https://bff.allencell.org/), which also includes datasets from individual scRNA-seq experiments.

Figure 1. Two strategies for generating and characterizing genetic tools.

Enhancer AAV Vector Screening and Optimization

Researchers built a cross-species (mouse/human) transcriptomic and epigenomic taxonomy at sub-class resolution by integrating historical genomic datasets with newly generated single-nucleus multiomic data (snMultiome). Mouse data were obtained from the primary somatosensory area (SSp), primary motor area (MOp), and primary visual area (VISp), while human data were collected from the middle temporal gyrus (MTG).

These approaches enabled the measurement of tens of thousands of molecular features in single cells, classification into molecularly defined cell types, and identification of marker genes and genomic enhancers consistent with specific cell types. Based on these findings, researchers designed and tested 1,164 unique enhancer AAV vectors, including 802 candidate sequences (643 mouse-derived and 159 human-derived). Approximately 40% (313 vectors) demonstrated targeting specificity.

Each putative enhancer sequence was assigned a unique ID: AiE = enhancers discovered by the Allen Institute. ExE = sequences based on coordinates reported by other research groups. The IDs are followed by four digits and a species identifier (“m” for mouse, “h” for human). Candidate enhancer sequences were amplified from their respective genomes and cloned upstream of a minimal promoter (minBG, minRho, minCMV) or an endogenous promoter in an AAV plasmid backbone, driving the expression of yellow fluorescent protein SYFP.

Figure 2. Enhancer AAV vector information on Addgene

(https://www.addgene.org/browse/article/28248370/)

The plasmids were packaged into PHP.eB AAV vectors, capable of crossing the blood-brain barrier, and delivered to C57BL/6J mice via retro-orbital (RO) injection. About four weeks post-injection, brain slice fluorescence images were first screened visually, followed by serial two-photon tomography (STPT) for whole-brain labeling assessment, and single-cell RNA sequencing (scRNA-seq) for determining cell-type specificity. Experiments focused on the mouse visual cortex to ensure data consistency.

Through core deletion and tandem optimization, SYFP2 mRNA expression levels from enhancer AAVs increased by an average of 839%, while maintaining stable specificity. Recombinase versions (e.g., Cre, FlpO) were also developed, with modifications such as Cre(R297T) mutation and adjustments to WPRE sequences to reduce off-target expression.

Figure 3. Screening enhancer AAVs in the mouse brain

The most valuable tools—those enabling genetic access to specific sub-classes or clusters—were designated with a “Hall of Fame” (HoF) label. This naming, manually assigned by Allen Institute scientists, considers factors such as specificity determined from scRNA-seq data and signal intensity of enhancer AAVs, helping researchers identify the best tools for targeting defined cell populations.

Figure 4. Hall of Fame (HoF) enhancer AAVs

Establishment of Transgenic Driver and Reporter Mouse Lines

Finally, researchers established and evaluated 15 transgenic driver mouse lines and 2 reporter lines, which can be used either independently or in combination with enhancer AAVs to achieve genetic access to even the most finely classified cortical subpopulations.
The two reporter lines (Ai193 and Ai224) contain independent transcription units that report the expression of Cre and Flp recombinases by expressing different fluorescent proteins:
Ai193: TICL-EGFP-WPRE-ICF-tdT-WPRE-hyg
Ai224: TICL-NLS-EGFP-ICF-NLS-dT-hyg

In these lines: GFP is expressed when Cre is present, tdTomato is expressed when Flp is present, Both fluorescent proteins are expressed simultaneously when Cre and Flp are co-expressed.
Based on the transcriptomic taxonomy of mouse cortical cell types, marker genes capable of labeling specific cell types (subclasses, supertypes, or clusters) were selected. Fifteen genes were chosen to generate Cre or Flp driver lines.

Glutamatergic driver lines: 11 marker genes were used, including Batf3, Parm1, Rxfp1, Chrna6, Slco2a1, Cplx3, Cpne4, Ctxn3, Gpr139, Npnt, and Slc17a7.
·Batf3-IRES2-FlpO-WPRE-neo primarily targeted the L5_IT_VISp_Batf3 cluster within the L5_IT subclass, but also labeled some L2/3 IT, other L5_IT, L6_CT cells, and microglia.
·Chrna6-IRES2-FlpO specifically labeled the L5_ET_Chrna6 cell type.

GABAergic driver lines: genes such as Lamp5, Sncg, and Chodl were used to construct driver lines.
·Lamp5-P2A-FlpO labeled Lamp5 GABAergic neurons but also labeled glutamatergic cells in layers 2–3, 5, and 6.
·Sncg-IRES-FlpO;Ai65F labeled the Sncg neuronal population as well as endothelial cells.

Figure 5. Comparison of transgenic reporter and driver mouse lines with selected enhancer AAVs.

Significance of the Study

This article reports the creation and public release of over 1,000 enhancer AAVs and 17 transgenic mouse lines as genetic tools. Their specificity was validated through single-cell sequencing and imaging technologies, and further optimized to improve performance. By establishing a cross-species cortical cell taxonomy, the study provides a standardized toolkit and data resource for cortical cell-type research, advancing our understanding of brain function and disease mechanisms. Moreover, the large-scale development workflow sets a methodological foundation for future innovations in neuroscience tool development.

Original article: https://doi.org/10.1016/j.cell.2025.05.002

The following table was compiled by the Brain Case Team, with information sourced from the supplementary materials of DOI: 10.1016/j.cell.2025.05.002. If you are interested in the related vectors, please feel free to contact us. bd@ebraincase.com

ID	Enhancer ID	Product Name	Cortical Target Cells	Cell Type	Addgene	Specificity (%)
BC-4795	AiE0680m	rAAV-AiE0680m-minBG-EGFP	L2-3_T	Glutamatergic excitatory neurons	224004	100
BC-4796	AiE0050m_3xC2	TAAV-AiE0050m_3xC2minCMV-EGFP	L4IT	Glutamatergic excitatory neurons	223974	97.65
BC-4797	AiE2182m_3xC2	rAAV-AiE2182m_3xC2-minBG-EGFP	L5IT	Glutamatergic excitatory neurons	224043	70.59
BC-4798	AiE0772m	rAAV-AiE0772m-minBG-EGFP	L6IT_Car3	Glutamatergic excitatory neurons	224000	73.47
BC-4799	AiE0456m	rAAV-AiED456m-minBG-EGFP	L5ET	Glutamatergic excitatory neurons	224006	100
BC-4800	AiE0674m	rAAV-AiE0674m-minBG-EGFP	L5ET	Glutamatergic excitatory neurons	224013	83.33
BC-4801	AiE0667m	rAAV-AiE0667m-minBG-EGFP	L5ET_Chrna6	Glutamatergic excitatory neurons	224017	96.67
BC-4802	AiE2575m	rAAV-AiE2575m-minBG-EGFP	L6_CT	Glutamatergic excitatory neurons	214570	90
BC-4803	AiE2103m	rAAV-AiE2103m-minBG-EGFP	Lamp5	GABAergic inhibitory interneurons	214480	100
BC-4804	AiE0219h	rAAV-hsA2-AiE0219h-minRho-EGFP	Mp	GABAergic inhibitory interneurons	230101	81.08
BC-4805	AiE0682h	rAAV-AiE0682h-minBG-EGFP	Sst Chodl	GABAergic inhibitory interneurons	191727	82.35
BC-4806	AiE0170h_3xC2	rAAV-AiE0170h_3xC2-minBG-EGFP	Sst	GABAergic inhibitory interneurons	224029	75.76
BC-4B07	AiE0140h	rAAV-hsA2-AiE0140h-minRho-EGFP	Pvalb	GABAergic inhibitory interneurons	163503	98.39
BC-4808	AiE0475m	rAAV-AiED475m-minBG-EGFP	Pvalb_chc	GABAergic inhibitory interneurons	229884	86.84
BC-4809	AiE0390h_3×C2	TAAV-AiE0390h_3×C2minBG-EGFP	Astro	Astrocytes	208143	100
BC-4810	AiE0387m	rAAV-AiE0387m-minBG-EGFP	Astro	Astrocytes	208133	100
BC-4811	AiE0395h	rAAV-AiE0395h-minBG-EGFP	Oligo	Oligodendrocytes	208146	100
BC-4B12	AiE0397m	rAAV-AiE0397m-minBG-EGFP	Oligo	Oligodendrocytes	208150	100
BC-4813	AiE2128m	rAAV-AiE2128m-minBG-EGFP	Endo	Endothelial cells and pericytes	220643	50

${dede:global.cfg_webname/}$

WhatsApp Business Account

Tel： +8618971215294

E-mail： BD@ebraincase.com

[Research Tool Highlight] Featured in Cell! Brain Case launches new product — Enhancer AAV Vectors, a breakthrough for research Tool !

Enhancer AAV Vector Screening and Optimization

Establishment of Transgenic Driver and Reporter Mouse Lines

Significance of the Study

How did you hear about BrainCase Biotech or our products?(Fill in this field to get a discount coupon)

Detailed requirements:

Gene ID or gene information:

Selection of the reporting gene:

Special Instructions:

Virus name/Detailed requirements:

Virus product library

News

Support

[Research Tool Highlight] Featured in Cell! Brain Case launches new product — Enhancer AAV Vectors, a breakthrough for research Tool !

Enhancer AAV Vector Screening and Optimization

Establishment of Transgenic Driver and Reporter Mouse Lines

Significance of the Study

Related products

Nat Biomed Eng | Woo-ping Ge and Wenzhi Sun’s teams develop the rAAV-miniBEND system: Breaking through the challenge of brain endothelial cell gene delivery and enabling cerebrovascular malformation modeling !